Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

Ginkgo Biloba: How Supportive is the Data?

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Patients around the world looking for the Holy Grail in staving off cognitive impairment have been using ginkgo biloba for years, to the tune of $1 billion in annual sales worldwide. How strong is the data to support this use? Dr. Jeffrey Kaye, director of the National Institute on Aging's Layton Aging and Alzheimer's Disease Center and the Oregon Center for Aging and Technology at Oregon Health and Sciences University, joins host Dr. Leslie Lundt to review key points of current research on ginkgo biloba.

Recommended
Details
Presenters
Comments
  • Overview

    Patients around the world looking for the Holy Grail in staving off cognitive impairment have been using ginkgo biloba for years, to the tune of $1 billion in annual sales worldwide. How strong is the data to support this use? Dr. Jeffrey Kaye, director of the National Institute on Aging's Layton Aging and Alzheimer's Disease Center and the Oregon Center for Aging and Technology at Oregon Health and Sciences University, joins host Dr. Leslie Lundt to review key points of current research on ginkgo biloba.

Schedule14 Dec 2024